Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 1876 AL 1890

Molecularly imprinted polymers for the recognition of biomarkers of certain neurodegenerative diseases

Pilvenyte G, Ratautaite V, Boguzaite R, Samukaite-Bubniene U, Plausinaitis D, Ramanaviciene A, Bechelany M, Ramanavicius A.

J Pharm Biomed Anal. 2023 May 10;228:115343. doi: 10.1016/j.jpba.2023.115343. Epub 2023 Mar 14.

[Parkinson's disease and Alzheimer type dementia-Pathophysiology and drug treatment approaches]

Dodel R.

Inn Med (Heidelb). 2023 Feb;64(2):113-120. doi: 10.1007/s00108-022-01463-0. Epub 2023 Jan 16.

Zebrafish as a Potential Model for Neurodegenerative Diseases: A Focus on Toxic Metals Implications

Paduraru E, Iacob D, Rarinca V, Plavan G, Ureche D, Jijie R, Nicoara M.

Int J Mol Sci. 2023 Feb 8;24(4):3428. doi: 10.3390/ijms24043428.

Brain insulin resistance linked Alzheimer's and Parkinson's disease pathology: An undying implication of epigenetic and autophagy modulation

Kakoty V, Kc S, Kumari S, Yang CH, Dubey SK, Sahebkar A, Kesharwani P, Taliyan R.

Inflammopharmacology. 2023 Apr;31(2):699-716. doi: 10.1007/s10787-023-01187-z. Epub 2023 Mar 23.

Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and Older

Brumm MC, Pierz KA, Lafontant DE, Caspell-Garcia C, Coffey CS, Siderowf A, Marek K.

Neurology. 2023 Apr 18;100(16):e1691-e1701. doi: 10.1212/WNL.0000000000207077. Epub 2023 Feb 27.

Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer's Disease and Parkinson's Disease

He A, Wang M, Li X, Chen H, Lim K, Lu L, Zhang C.

Int J Mol Sci. 2023 Jul 4;24(13):11054. doi: 10.3390/ijms241311054.

Assessing causal relationship between circulating cytokines and age-related neurodegenerative diseases: a bidirectional two-sample Mendelian randomization analysis

Yin Z, Chen J, Xia M, Zhang X, Li Y, Chen Z, Bao Q, Zhong W, Yao J, Wu K, Zhao L, Liang F.

Sci Rep. 2023 Jul 29;13(1):12325. doi: 10.1038/s41598-023-39520-9.

Preclinical Evidence-based Review on Therapeutic Potential of Eugenol for the Treatment of Brain Disorders

Goyal A, Solanki A, Verma A.

Curr Mol Med. 2023;23(5):390-400. doi: 10.2174/1566524022666220525145521.

Fluid and Biopsy Based Biomarkers in Parkinson's Disease

Coughlin DG, Irwin DJ.

Neurotherapeutics. 2023 Jul;20(4):932-954. doi: 10.1007/s13311-023-01379-z. Epub 2023 May 3.

Role of Bmal1 and Gut Microbiota in Alzheimer's Disease and Parkinson's Disease Pathophysiology: The Probable Effect of Melatonin on Their Association

Khezri MR, Esmaeili A, Ghasemnejad-Berenji M.

ACS Chem Neurosci. 2023 Nov 1;14(21):3883-3893. doi: 10.1021/acschemneuro.3c00418. Epub 2023 Oct 12.

Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer's disease

Herden JM, Hermann P, Schmidt I, Dittmar K, Canaslan S, Weglage L, Nuhn S, Volpers C, Schlung A, Goebel S, Kück F, Villar-Piqué A, Schmidt C, Wedekind D, Zerr I.

Alzheimers Res Ther. 2023 Jun 8;15(1):106. doi: 10.1186/s13195-023-01249-y.

Advances in the Application of Induced Pluripotent Stem Cells in Alzheimer's Disease and Parkinson's Disease

Xu Y, Wang S, Zhu P.

Curr Stem Cell Res Ther. 2023;18(2):154-162. doi: 10.2174/1574888X17666220426114050.

Oxidative Stress and Aging as Risk Factors for Alzheimer's Disease and Parkinson's Disease: The Role of the Antioxidant Melatonin

Tchekalarova J, Tzoneva R.

Int J Mol Sci. 2023 Feb 3;24(3):3022. doi: 10.3390/ijms24033022.

Entropy and fractal analysis of brain-related neurophysiological signals in Alzheimer's and Parkinson's disease

Averna A, Coelli S, Ferrara R, Cerutti S, Priori A, Bianchi AM.

J Neural Eng. 2023 Sep 25;20(5). doi: 10.1088/1741-2552/acf8fa.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias